{
    "symbol": "PEN",
    "quarter": 2,
    "year": 2022,
    "date": "2022-08-07 09:51:17",
    "content": " Turning to our vascular business, we reported growth of 22.7% year-over-year to $123.5 million in the second quarter. Turning to our neurovascular business, our revenue grew to $84.8 million in the second quarter of 1.5% on a year-over-year basis, and 4.6% sequentially. Moving to revenue by franchise, revenue from our vascular business grew to $123.5 million in the second quarter of 2022, an increase of 22.7% reported and 24.5% in constant currency compared to the same period last year. Revenue from our neuro business was $84.8 million in the second quarter of 2022, an increase of 1.5% reported and 4.3% in constant currency compared to the same period a year ago. For the back half of 2022, we will be more disciplined in our discretionary spending, and together with over $10 million reduction in immersive healthcare operating expenses in the next 12 months, we expect continued operating margin expansion in sequential quarters. Your line is open. Your line is open. Yeah, thanks for the question. Your line is open. Your line is open. Yeah, thanks for the question. Your line is open. Yeah, it\u00e2\u0080\u0099s a great question. Yeah, it\u00e2\u0080\u0099s a great question. Your line is open. Your line is open."
}